Teva Can't Swap Out Expert In HIV Drug Patent Trial

Law360, New York (February 7, 2013, 5:14 PM EST) -- A New York federal judge on Wednesday shot down Teva Pharmaceuticals USA Inc.’s bid to switch out its expert witness for its upcoming trial versus Gilead Sciences Inc. over patents for HIV drugs, finding substituting an expert at this stage would be unfair to Gilead.

U.S. District Judge Richard J. Sullivan rejected Teva's request to bring in a new expert for the trial over a recent Federal Circuit opinion finding Dr. Ashim Mitra was less than truthful in another Teva suit, saying he could find no...
To view the full article, register now.